Kathryn E King

3PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 17, 2021
FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer.

Melanie Royce, Christy L Osgood, Anup K Amatya

|Jul 10, 2019
Intersection of the p63 and NF-κB pathways in epithelial homeostasis and disease.

Kathryn E King, Andrea L George, Nozomi Sakakibara

Pageof 1